430 related articles for article (PubMed ID: 26877609)
21. A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer.
Wang X; Yan SK; Dai WX; Liu XR; Zhang WD; Wang JJ
Int J Cancer; 2010 Dec; 127(12):2841-50. PubMed ID: 21351263
[TBL] [Abstract][Full Text] [Related]
22. Metabolomic profiling of oesophago-gastric cancer: a systematic review.
Abbassi-Ghadi N; Kumar S; Huang J; Goldin R; Takats Z; Hanna GB
Eur J Cancer; 2013 Nov; 49(17):3625-37. PubMed ID: 23896378
[TBL] [Abstract][Full Text] [Related]
23. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
24. Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway.
Chen F; Zhuang M; Zhong C; Peng J; Wang X; Li J; Chen Z; Huang Y
Oncol Rep; 2015 Jan; 33(1):457-63. PubMed ID: 25333894
[TBL] [Abstract][Full Text] [Related]
25. Novel CD9-targeted therapies in gastric cancer.
Murayama Y; Oritani K; Tsutsui S
World J Gastroenterol; 2015 Mar; 21(11):3206-13. PubMed ID: 25805926
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of metabolomic profiling of gastric cancer and esophageal cancer.
Huang S; Guo Y; Li Z; Zhang Y; Zhou T; You W; Pan K; Li W
Cancer Biol Med; 2020 Feb; 17(1):181-198. PubMed ID: 32296585
[No Abstract] [Full Text] [Related]
27. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
28. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
Zhao J; Yang C; Guo S; Wu Y
Int J Clin Exp Pathol; 2015; 8(9):10784-91. PubMed ID: 26617790
[TBL] [Abstract][Full Text] [Related]
29. [The Warburg effect: from theory to therapeutic applications in cancer].
Razungles J; Cavaillès V; Jalaguier S; Teyssier C
Med Sci (Paris); 2013 Nov; 29(11):1026-33. PubMed ID: 24280507
[TBL] [Abstract][Full Text] [Related]
30. Management of advanced gastric cancer.
Price TJ; Shapiro JD; Segelov E; Karapetis CS; Pavlakis N; Van Cutsem E; Shah MA; Kang YK; Tebbutt NC
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):199-208; quiz 209. PubMed ID: 22375525
[TBL] [Abstract][Full Text] [Related]
31. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
32. Anti-Warburg effect of rosmarinic acid via miR-155 in gastric cancer cells.
Han S; Yang S; Cai Z; Pan D; Li Z; Huang Z; Zhang P; Zhu H; Lei L; Wang W
Drug Des Devel Ther; 2015; 9():2695-703. PubMed ID: 26056431
[TBL] [Abstract][Full Text] [Related]
33. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptors in gastric cancer: Advances and perspectives.
Ur Rahman MS; Cao J
World J Gastroenterol; 2016 Feb; 22(8):2475-82. PubMed ID: 26937135
[TBL] [Abstract][Full Text] [Related]
35. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
Gou WF; Yang XF; Shen DF; Zhao S; Liu YP; Sun HZ; Takano Y; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19841-67. PubMed ID: 25904053
[TBL] [Abstract][Full Text] [Related]
36. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy.
Zhang D; Li J; Wang F; Hu J; Wang S; Sun Y
Cancer Lett; 2014 Dec; 355(2):176-83. PubMed ID: 25218591
[TBL] [Abstract][Full Text] [Related]
37. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.
Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D
Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828
[TBL] [Abstract][Full Text] [Related]
38. Targeted therapy for gastric adenocarcinoma.
Almhanna K
Adv Pharmacol; 2012; 65():437-70. PubMed ID: 22959034
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
40. Metabolomic analysis reveals altered metabolic pathways in a rat model of gastric carcinogenesis.
Gu J; Hu X; Shao W; Ji T; Yang W; Zhuo H; Jin Z; Huang H; Chen J; Huang C; Lin D
Oncotarget; 2016 Sep; 7(37):60053-60073. PubMed ID: 27527852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]